Independent psychedelic field guideEducational information — not medical adviceOur research standards
HomeConditionsAnxiety & distress
Condition path · 04 connected medicines

Anxiety & distress

Fear · uncertainty · serious illness

Studies often focus on anxiety linked to depression, serious illness, or existential distress rather than treating every kind of anxiety as one category.

ASSOCIATION IS NOT A TREATMENT CLAIM

Medicines appear here because of current research, a specific established clinical context, or sustained public interest. Inclusion does not establish approval, suitability, safety, or effectiveness for an individual.

01 / START HERE

A condition is a starting point, not the whole story.

Anxiety can mean generalized worry, panic, social fear, trauma-related arousal, or distress connected to serious illness. Psychedelic studies usually define a narrower population, so findings should not be flattened into a claim about “anxiety” as a whole.

EVIDENCE LENS

Current psilocybin and LSD research includes anxiety and distress in specific settings. 5-MeO-DMT and mescaline connections are earlier and less condition-specific. Small samples, difficult blinding, supportive-session effects, and carefully screened participants limit broad conclusions.

FOR GUIDES & FACILITATORS

Ask what fear is doing, what reliably escalates it, whether panic or dissociation is present, which medicines are being taken, and whether the setting can support distress without coercion or false reassurance.

02 / CONNECTED MEDICINES

Medicines associated with Anxiety & distress

Open a field guide for the felt experience, common names, research signal, interactions, contraindications, safety, and legal context unique to each medicine.

KEEP THE CONTEXT

The medicine is one variable.

Diagnosis, intention, medications, physical health, culture, prior experience, consent, setting, support, and follow-up can all change the meaning and risk of a psychedelic experience.